Literature DB >> 17376622

Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study.

Tetsuya Marui1, Ikuko Funatogawa, Shinko Koishi, Kenji Yamamoto, Hideo Matsumoto, Ohiko Hashimoto, Eiji Nanba, Hisami Nishida, Toshiro Sugiyama, Kiyoto Kasai, Keiichiro Watanabe, Yukiko Kano, Nobumasa Kato, Tsukasa Sasaki.   

Abstract

Autism (MIM 209850) is a severe neurodevelopmental disorder characterized by disturbances in social interaction and communication, by repetitive body movements and restricted interests, and by atypical language development. Several twin and family studies have shown strong evidence for genetic factors in the etiology of autism. Glutamate is a major excitatory neurotransmitter in the human brain. Glutamate systems are involved in the pathophysiology of autism. There are many similarities between the symptoms evoked by glutamate antagonist treatment and symptoms of autism found in several human and animal studies. To elucidate the genetic background of autism, we analyzed the relationship between three single nucleotide polymorphisms (SNPs) of the Tachykinin 1 gene (TAC1) and autism, because TAC1 is located in the candidate region for autism and produces substance P and neurokinins. These products modulate glutamatergic excitatory synaptic transmission and are also involved in inflammation. Many different inflammation-related mechanisms could be involved in the autistic brain. Therefore, TAC1 may have some functions associated with the presumable pathophysiology of autism. We compared the allele and haplotype frequencies between autistic patients (n=170) and normal controls (n=214) in the Japanese population, but no significant difference was observed. Thus, the TAC1 locus is not likely to play a major role in the development of autism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376622     DOI: 10.1016/j.braindev.2007.01.010

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  6 in total

1.  The levels of blood mercury and inflammatory-related neuropeptides in the serum are correlated in children with autism spectrum disorder.

Authors:  Gehan Ahmed Mostafa; Geir Bjørklund; Mauricio A Urbina; Laila Yousef Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2016-01-06       Impact factor: 3.584

2.  The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-12-21       Impact factor: 8.322

3.  The gene expression profile of peripheral blood mononuclear cells from EV71-infected rhesus infants and the significance in viral pathogenesis.

Authors:  Ying Zhang; Erxia Yang; Jing Pu; Longding Liu; Yanchun Che; Jingjing Wang; Yun Liao; Lichun Wang; Dong Ding; Ting Zhao; Na Ma; Ming Song; Xi Wang; Dong Shen; Donghong Tang; Hongtai Huang; Zhixiao Zhang; Dai Chen; Mingfei Feng; Qihan Li
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

4.  Identification of rare copy number variations reveals PJA2, APCS, SYNPO, and TAC1 as novel candidate genes in Autism Spectrum Disorders.

Authors:  Tania Bitar; Walid Hleihel; Sylviane Marouillat; Sandrine Vonwill; Marie-Laure Vuillaume; Michel Soufia; Patrick Vourc'h; Frederic Laumonnier; Christian R Andres
Journal:  Mol Genet Genomic Med       Date:  2019-06-29       Impact factor: 2.183

5.  Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence.

Authors:  Chamindi Seneviratne; Nassima Ait-Daoud; Jennie Z Ma; Guobo Chen; Bankole A Johnson; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2009-06-24       Impact factor: 7.853

6.  Assessment of Tachykinin Receptor 3' Gene Polymorphism rs3733631 in Rosacea.

Authors:  Anthony Karpouzis; Paschalis Avgeridis; Gregory Tripsianis; Elisavet Gatzidou; Niki Kourmouli; Stavroula Veletza
Journal:  Int Sch Res Notices       Date:  2015-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.